SCHEMBL21067802

SCHEMBL21067802

Nc1ncnc2c(CN3C[C@H](CSCc4ccccc4)[C@@H](O)C3)c[nH]c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MTAP Q13126 16/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12715583 1.00 MTAP (1.00) MTAP
SCHEMBL4736877 1.00 MTAP (1.00) MTAP
SCHEMBL24063045 1.00 MTAP (1.00) MTAP
SCHEMBL4752750 0.91 MTAP (0.83) MTAP
SCHEMBL4736908 0.91 MTAP (0.83) MTAP
SCHEMBL12945171 0.89 MTAP (1.00) MTAP
SCHEMBL18975182 0.89 MTAP (1.00) MTAP
SCHEMBL24063155 0.88 MTAP (0.79) MTAP
SCHEMBL10064930 0.87 MTAP (0.77) MTAP
SCHEMBL4736743 0.85 MTAP (0.75) MTAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed